Tranexamic acid functions as an antifibrinolytic agent. It blocks the lysine-binding sites on plasminogen molecules, preventing the conversion of plasminogen to plasmin. This action stabilizes the clot by protecting fibrin from degradation, effectively reducing bleeding.
